Dr. Christina Herder
Board member Dr. Christina Herder
Executive Leadership Team
The University of Queensland
Norway
Biography
Dr. Herder is the CEO of Modus Therapeutics AB, a Swedish drug development company, since 2014. She has over 20 years of experience from the life science industry, both from the areas of drug development as well as business development. Previous positions include Sobi, where she built up the portfolio management function and worked with Corporate Development.
Research Interest
She holds a PhD from Royal Institute of Technology in Stockholm, Sweden, and an MBA from Stockholm University. Dr. Herder has previously served as Board member of Akinion Pharmaceuticals AB. She has been a Board member of PCI Biotech Holding ASA since 2015.
